Home

On:

The US Food and Drug Administration has granted a group of researchers approval to proceed with the use of the controversial drug psilocybin, a psychedelic compound naturally produced in about 200 species of mushrooms, to treat patients suffering from treatment-resistant depression. This comes as welcome news for researchers that study psychedelic drugs, as current drug laws inhibit the study into the potential medical effects that the forbidden fungus may have to offer.
read more

On:

Recent research has revealed that Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).

Schizophrenia is a mental illness with symptoms that can include delusions and hallucinations. Since schizophrenia is more prevalent in high latitudes and cold climates, researchers have theorized vitamin D may be connected to the disorder.
read more

On:

The power of the eye has always fascinated man, who has declared since ancient times that these enigmatic visual organs are "the mirrors of our soul". The latest developments in psychiatry may now add some weight to this concept, as a recent research study has indicated that the eye may hold the key to the diagnosis of severe mental illness.
read more